
zzso that there are no ethical concerns, the comparison of an active drug with zzso in a zzso zzso clinical trial provides the most convincing way to demonstrate the efficacy of a new experimental zzso However, in a zzso clinical trial it is not sufficient to demonstrate merely a statistically significant treatment zzso Regulatory authorities strongly recommend to assess additionally whether the observed treatment difference is also of clinical zzso The inherent issue is the necessity of the a zzso definition of what constitutes a clinically relevant difference in zzso This problem can be solved in a zzso study by including an active control zzso We address the necessary conditions in the gold standard design which allow the claim of efficacy for the new treatment with particular focus on zzso zzso 

